Research article · 11 Jun 2026
Research articlePublished 22 Jan 2024
A Prospective Single-Donor Cellular Analysis of Two Different Intradiscal Autologous Platelet-Rich Plasma Systems
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Purpose: Intradiscal autologous platelet rich plasma (PRP) is a therapy for patients with chronic discogenic lower back pain. Recent clinical studies suggest that a PRP preparation with a higher platelet concentration may improve clinical outcomes. The purpose of this study was to compare a newly designed PRP system (DiscCath™, LLC) with a traditional PRP system (Emcyte Corporation) to determine if higher platelet concentrations were attainable from the same donor. Methods: Prospective single-donor cohort study at an outpatient interventional orthobiologics clinic involving 31 participants (17 male and 14 female) who supplied 64 distinct PRP samples (one patient’s PRP was analyzed on two separate treatment appointments). Baseline peripheral blood cell count data, and PRP cell count data that included absolute platelet count (ABS PLT), platelet fold increase (PLT Fold), white blood cell counts and differential (WBC; LYM, MON, GRA), and hematocrit percentage (HCT). Results: DiscCath™ produced a PRP product with a statistically higher ABS PLT (6.95 vs 5.65 billion platelets) and higher PLT Fold (15.92X vs 12.48X) when compared to EmCyte. DiscCath™ also produced a PRP with a higher ABS WBC (44.63 vs 41.86 million) and a lower HCT (10.30 vs 11.54 percent) when compared to EmCyte, which did not achieve statistical significance. Conclusion: The DiscCath™ PRP System concentrated platelets to higher levels than the Emcyte PRP System. This may have clinical implications in optimizing the intradiscal treatment of patients with degenerative disc disease. Clinical studies are needed to evaluate if the DiscCath™ PRP System improves clinical outcomes in intradiscal PRP therapy. Keywords: Platelet-rich plasma, Intradiscal, Platelets, Systems, Single-Donor
Subjects
EngineeringAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Regenerative Medicine.
Research article · 8 Aug 2025
Human Umbilical Cord-Derived Mesenchymal Stem Cells in Combination with Small Extracellular Vesicles Prevent the Development of Fibrosis and Cirrhosis and Improve Survival in Wistar Rats Receiving CCl₄
Opinion · 20 Feb 2025
CAR-T Cell Therapy: Expanding Applications beyond Hematologic Malignancies
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Regenerative Medicine
- SubjectEngineering
- BylineArticles whose byline prints “Jennifer Solomon”
- BylineArticles whose byline prints “Mohammed Mostafa Sharaf”
- BylineArticles whose byline prints “Christopher Kyriakides”
- BylineArticles whose byline prints “Richard Abiuso”
- BylineArticles whose byline prints “Nicholas Beatty”
- BylineArticles whose byline prints “Christopher Lutz”
- BylineArticles whose byline prints “Meredith Prysak”
- BylineArticles whose byline prints “Gregory Lutz”
